Annette Gilchrist has built her research program around that premise. Her lab studies chemokine receptor CCR1 in multiple myeloma and cancer-to-bone metastasis, free fatty The years of research that followed came directly from not dismissing it. , and muscarinic M2 and M3 19:28 CCR1 in multiple myeloma - osteoclast/osteoblast imbalance and the cancer-to-bone Instead, she discovered research and started her Ph.D. the day she should have started medical school

Weill Cornell Graduate School of Medical Sciences in New York City, studying epigenetic changes in cancer During her postdoctoral training at New York University School of Medicine, her research focused on cellular

Oncology Ignored GPCRs for Decades — and Is Paying Attention Now Twenty years ago, cancer biologists Richard Henderson at the Laboratory of Molecular Biology in Cambridge, UK. Marshall is the VP Head of Neuroscience Discovery and Head of Discovery UK, Global Head of Neuroscience discovery research leading teams in West Point, Boston, and London at MSD. Fiona Marshall on the web LinkedIn Twitter Google Scholar MSD UK Dr.

His undergraduate thesis work on studying the biochemical mechanisms of flavonoids in cancer using nuclear been recognized with the MRC LMB's Max Perutz Prize for outstanding Ph.D. work and has been elected a Research

Her research focuses on understanding the fundamental cell biological mechanisms regulating GPCR activity Her work is currently funded by Biotechnology and Biological Sciences Research Council (BBSRC), Diabetes UK, Wellcome Trust, and the Medical Research Council. Aylin Hanyaloglu on the web LinkedIn Researchgate Twitter Imperial College London Elsevier Loop Dr.

to Webinars 📅 Tuesday, March 3, 2026 at 10:00:00 AM EST 🤝 Webinar in collaboration with: Celtarys Research Johannes Broichhagen Group Leader Leibniz Research Institute for Molecular Pharmacology (FMP), Berlin Since 2020, he leads an independent research group at the FMP Berlin. Montpellier before establishing his independent laboratory at Imperial College London as a Diabetes UK Cancel anytime. Sign Up for Free

During four years of postdoctoral research at ETH Zurich and the Paul Scherrer Institute in Switzerland Cell Signaling and Cancer Metastasis Discussion Aurelien Rizk and Yamina Berchiche had a detailed conversation Yamina shared her research experience, emphasizing the fascination of understanding how cells respond to gradients and signals, particularly in relation to cancer metastasis.

After switching to biotech, Murat has built cell imaging software and lab robots to accelerate cancer research and automated Thermo Fisher Scientific’s gene synthesis workflows.

Hauser's research program asks a pointed question: if a patient fails to respond to a psychiatric drug Research that bypasses clinical input tends to stay in the research community. medicine cluster in Copenhagen and at the Institute of Biological Psychiatry in Roskilde working with the UK , UK, where he was working on the impact of genetic variations on drug response. He received the “HC Ørsted Research talent prize” and “Bayer Pharmaceuticals Ph.D.

This week's GPCR roll-up includes the latest insights, research discoveries, and advancements. Conformational Landscapes Rajan Lamichhane Discovery of CCR8 Antagonist IDOR-1136-5177 for the Treatment of Cancer Therapeutics Summit - USA April 2 - 3, 2025 | New therapeutic modalities: Transforming receptor pharmacology - UK G Protein-coupled Receptor Kinases and Arrestins - USA December 16 - 18, 2025 |Pharmacology 2025 - UK mediators of tumour-to-TME crosstalk Discovery of CCR8 Antagonist IDOR-1136-5177 for the Treatment of Cancer

The company’s mission is to discover and develop highly effective cancer therapeutics by targeting heteromers Cardarelli heads the team of talented researchers that will be expanding at the US site. Dr.

world-class and diverse GPCR scientists working in the arenas of structure and signaling, neuroscience, cancer We are thrilled by the overwhelming interest in this event by the GPCR research community. postdoctoral fellows and principal investigators can have stimulating discussions and debates on GPCR research

the Department of Physiology and Pharmacology at Karolinska Institute in Stockholm, where he leads research receptors: 10 subtypes, 19 ligands, almost no drugs 20:22 When Wnt–frizzled signaling goes wrong — cancer Gunnar Schulte Gunnar Schulte is a Professor in receptor pharmacology and research group leader for the Gunnar Schulte is also the scientific secretary of the Swedish Society for Medical Research (SSMF) and Most importantly my research team tries to understand underlying mechanisms of WNT-receptor interaction

Kenakin then moved to the UK, where he did a post-doctoral fellowship in University College London with His next stop took him to Burroughs-Wellcome (BW) in Research Triangle Park (RTP) in North Carolina USA Terry Kenakin on the web LinkedIn UNC Department of Pharmacology Amazon ResearchGate Pubmed . Dr.

As part of the degree, she undertook a 1-year research-based placement at the Charles Perkins Centre From here, she returned to the UK. Annabelle Milner on the web Linkedin Researchgate Pubmed Dr. GPCR Unlock the Full Dr.

My postdoctoral work, conducted at the University of Bristol, UK, in Christopher Lowry's lab, examined Research in my lab is currently focused on understanding the signal transduction pathways activated by Gasser on the web Gasser Lab Marquette University Google Scholar ResearchGate LinkedIn Twitter Dr.

After a PhD on allosteric modulation of dopamine receptors in Philip Strange's UK lab and a postdoc at His independent research focuses on developing accessible mathematical tools for kinetic analysis of His ongoing research exists to close that gap. 3. Early-Career Researchers Know More Than They Think Hoare makes an argument that surprised him when he He then moved to the National Institute of Mental Health, researching pharmacological mechanisms of Class

Laura Bohn at Scripps Research Institute. opioid antinociception in one context, drives chronic pain in another, and functions as a mitogen in cancer Laura Bohn’s lab at Scripps Research Institute in Florida.

Prior to these roles this he was Head of Pharmacology at Heptares Therapeutics Ltd., a UK-based biotechnology Prior to joining Heptares, Chris was a neuroscience researcher at GlaxoSmithKline, UK (1998-2009). He has published over 70 research articles, reviews and book chapters on drug discovery, which have been

In this conversation, Arey traces the full arc of how a pharmaceutical research program is born, resourced About the Guest Brian Arey is a pharmacologist and physiologist with over 25 years of pharmaceutical research led mechanistic pharmacology operations and served as interim head of a 70-person cross-functional research Arey describes early-stage drug discovery as structurally similar to academic research - hypothesis-driven Arey calls this one of the most important and least instinctive skills in pharmaceutical research - and

ABOUT THE GUEST Chris Tate is a group leader at the MRC Laboratory of Molecular Biology in Cambridge, UK , where his research focuses on the structural and biochemical study of membrane proteins, with particular a protein with no connection to GPCRs - produced a light-bulb recognition that reshaped his entire research After obtaining a research fellowship at Girton College (Cambridge) he moved to the LMB in 1992 to work Chris Tate on the web LinkedIn ResearchGate Pubmed Google Scholar Sosei Heptares Wikipedia MRC Laboratory

His research focuses on novel paradigms of drug action at GPCRs, particularly allosteric modulation and Since 2014, Clarivate Analytics have annually named him a Highly Cited Researcher in ‘Pharmacology & Targets Arthur shared his decision to undertake a postdoctoral position with Nigel Bird's lab in the UK GPCR researchers in Australia and the initiation of a successful series of conferences. and its capacity to translate research into therapeutic commercialization.

His research focuses on novel paradigms of drug action at GPCRs, particularly allosteric modulation and Since 2014, Clarivate Analytics have annually named him a Highly Cited Researcher in ‘Pharmacology & Targets Arthur shared his decision to undertake a postdoctoral position with Nigel Bird's lab in the UK GPCR researchers in Australia and the initiation of a successful series of conferences. and its capacity to translate research into therapeutic commercialization.

Trained as a biochemist, he completed a PhD in protein engineering (Cambridge, UK) with Sir Gregory Winter Since then Oliver has worked at the University of Geneva, where his research on peptide engineering and high-profile publications and new intellectual property, and at the Mintaka Foundation for Medical Research

a molecular pharmacologist at the University of Nottingham, to discuss his scientific journey, GPCR research Folding to GPCRs – How Dmitry transitioned from biophysics and protein folding to cannabinoid receptor research Interdisciplinary Research & Future Directions – Exploring combinatorial drug actions, receptor interactions MRC Centre for Protein Engineering and later at the MRC Laboratory of Molecular Biology in Cambridge, UK

Graciela Piñeyro — who leads an opioid receptor pharmacology group at the CHU Sainte-Justine Research Recent β-arrestin knockout work from Australia, Germany, and the UK has converged on a similar sobering Graciela Piñeyro is a principal investigator at the CHU Sainte-Justine Research Center and a professor Newer knockout work from groups in Australia, Germany, and the UK has shown that respiratory depression Graciela Pineyro - CHU Ste-Justine Research Centre Pineyro Lab Publications on Google Scholar Pineyro

highlights the role of interdisciplinary collaboration in accelerating innovation in diabetes and obesity research Originally trained as a Veterinary Surgeon , he completed postdoctoral research at the CNRS in Montpellier before establishing his independent laboratory at Imperial College London as a Diabetes UK RD Lawrence

He has held four Canada Research Chairs since 2001 and was previously a Heart and Stroke Foundation of His research career has focused on the investigation of the regulation of G protein-coupled receptors He currently holds multiple research grants from the Canadian Institutes of Health Research (CIHR) for his research investigating the role of metabotropic glutamate receptor signaling in Huntington’s and Stephen Ferguson on the web Carlton University Canada Research Chairs Twitter ResearchGate LinkedIn Dr

He has held four Canada Research Chairs since 2001 and was previously a Heart and Stroke Foundation of His research career has focused on the investigation of the regulation of G protein-coupled receptors He currently holds multiple research grants from the Canadian Institutes of Health Research (CIHR) for his research investigating the role of metabotropic glutamate receptor signaling in Huntington’s and Stephen Ferguson on the web Carlton University Canada Research Chairs Twitter ResearchGate LinkedIn Dr

Industry Collaboration How do GPCR tools move from individual academic labs into broad use across the research Joining the conversation are Maria Majellaro (CSO and co-founder of Celtarys Research), Johannes Broichhagen at the CIQUS Research Center in Spain. Johannes Broichhagen is a group leader at the Leibniz Research Institute for Molecular Pharmacology ( Scholar Lab Website Leibniz Research Institute for Molecular Pharmacology (FMP) Profile David Hodson